APRE Aprea Therapeutics, Inc.
Nasdaq · SEC CIK 1781983 · EDGAR
- Bought, last 12 months
- $61.0K 4 purchases by 3 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 103 since 2021-07-01, latest 2026-06-17 19:09
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Duey Marc | Dir | $25.1K | — |
| Gilad Oren | Pres, CEO, Dir | $25.0K | — |
| Hamill John P. | CFO, SrVP, Prin Fin, Acct Ofcr | $10.9K | — |
| Pamukcu Rifat | Dir | — | — |
| Gruia Gabriela | Dir | — | — |
| Seizinger Bernd R. | Dir | — | — |
| Grissinger Michael | Dir | — | — |
| Peters Richard | Dir | — | — |
| BIZZARI JEAN-PIERRE | Dir | — | — |
| HENNEMAN JOHN B III | Dir | — | — |
Transactions 110
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-20 | 2021-09-16 | APRE | Attar Eyal C. | SVP, Chief Medical Off | S - Sale | $4.68 | -16.0K | 83.0K | -16% | -$74.7K | |
| 2021-09-14 | 2021-09-10 | APRE | Korbel Gregory Alan | Chief Business Off | F - Tax | $4.59 | -1,724 | 22.6K | -7% | -$7,913 | |
| 2021-08-27 | 2021-08-25 | APRE | Korbel Gregory Alan | Chief Business Off | F - Tax | $3.98 | -1,149 | 24.4K | -5% | -$4,573 | |
| 2021-08-27 | 2021-08-25 | APRE | Attar Eyal C. | SVP, Chief Medical Off | F - Tax | $3.98 | -9,032 | 99.0K | -8% | -$35.9K | |
| 2021-08-27 | 2021-08-25 | APRE | Coiante Scott M | SVP, CFO | F - Tax | $3.98 | -7,534 | 91.5K | -8% | -$30.0K | |
| D | 2021-07-01 | 2021-06-30 | APRE | Peters Richard | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 |
| D | 2021-07-01 | 2021-06-30 | APRE | Kelly Michael Aaron | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 |
| D | 2021-07-01 | 2021-06-30 | APRE | HENNEMAN JOHN B III | Dir | A - Grant | $0.00 | +4,610 | 9,610 | +92% | $0 |
| D | 2021-07-01 | 2021-06-30 | APRE | Namouni Fouad | Dir | A - Grant | $0.00 | +4,610 | 4,610 | New | $0 |
| D | 2021-07-01 | 2021-06-30 | APRE | Seizinger Bernd R. | Dir | A - Grant | $0.00 | +4,610 | 268.6K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations